ADVANCED RENAL CELL CARCINOMA
Clinical trials for ADVANCED RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World data shows promise for kidney cancer drug combo
Disease control CompletedThis study observed 311 adults with advanced kidney cancer who received cabozantinib (a targeted therapy) plus nivolumab (an immunotherapy) as their first treatment. Researchers tracked how long patients lived and how long tumors stayed under control in real-world settings. The g…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Immunotherapy duo shows promise in kidney cancer battle
Disease control CompletedThis phase 3 trial compared a combination of two immunotherapy drugs (nivolumab and ipilimumab) against the standard drug sunitinib in over 1,000 people with untreated advanced or metastatic kidney cancer. The study measured how well the tumors shrank, how long patients lived wit…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can an app help kidney cancer patients manage treatment side effects?
Knowledge-focused CompletedThis study looked at whether a software program called Carevive could help patients with advanced kidney cancer track side effects from their oral targeted therapy or immunotherapy. 21 patients used the software to report symptoms and received self-care tips. The goal was to see …
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Cancer moonshot study banks tissue to unlock genetic secrets
Knowledge-focused CompletedThis completed study collected blood and tumor tissue from 64 patients with advanced cancers (like melanoma, breast, lung, and kidney cancer) to study genetic changes and treatment resistance. The samples are stored for future research, including genomic analysis. No new treatmen…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC